The world's first SARS inactivated vaccine Phase I clinical study results was unblinded
Started study on pandemic influenza vaccine against human infection with highly pathogenic avian influenza (H5N1)
SINOVAC shares were listed on the American Stock Exchange (AMEX)
EN
